
October 9, 2024
RegMed Investors’ (RMi) pre-open: another bout of volatility, our benefit?
October 8, 2024
RegMed Investors (RMi) Closing Bell: sector slightly spikes
October 8, 2024
RegMed Investors’ (RMi) pre-open: Bending any trend, a delicate balance
October 7, 2024
RegMed Investors (RMi) Closing Bell: no joy
October 7, 2024
RegMed Investors’ (RMi) pre-open: record highs, lay low
October 4, 2024
RegMed Investors (RMi) Closing Bell: attention returned to the oversold cell and gene therapy sector
October 4, 2024
RegMed Investors’ (RMi) pre-open: tensions horns confidence
October 3, 2024
RegMedInvestors (RMi) Research Note: Editas Medicine asset sale raises $57+ M non -dilutive financing
October 3, 2024
RegMed Investors (RMi) Closing Bell: this a.m.’s calling-out the downside, didn’t work
October 3, 2024
RegMed Investors’ (RMi) pre-open: Flippin’ the bird
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors